Harbarth 1999.
| Methods | Double‐blind, randomised controlled trial | |
| Participants | Patients colonized with MRSA. Mupirocin: 48 Placebo: 50. No significant difference between both groups. | |
| Interventions | Mupirocin or placebo. Twice daily for 5 days. | |
| Outcomes | S. aureus infection rate. | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment? | Unclear risk | Unclear |
| Blinding? participants | Low risk | |
| Blinding? investigator | Low risk | |
| Blinding? outcome assessor | Low risk | |
| Blinding? data analysis | Low risk | |
| Intention to treat | Low risk | reported and confirmed |
| Loss to follow up | High risk | |